Seminar by Mr. Tetsuo Nakamura, Special Advisor to Eiseikai Medical Corporation, titled ‘More Complex Home Healthcare Management: Where Do We Go From Here?’, to be held on Saturday, July 18, 2026!! – Iza!

Mr. Tetsuo Nakamura, Special Advisor to Eiseikai Medical Corporation, will hold a seminar on July 18, 2026, on the theme of “More Complex Home Healthcare Management.” This news highlights specific issues in medical M&A and business succession, such as group participation leveraging economies of scale and tax schemes including transitions to specified medical corporations or social medical corporations, in the context of the outlook and challenges for home healthcare management after the 2026 Triple Revision. It provides important insights for medical institutions seeking next-generation management strategies.

The seminar titled “More Complex Home Healthcare Management,” to be held on July 18, 2026, is particularly timely as it takes place immediately after the next medical fee revision (effective April 2026) and will discuss the specific challenges and future directions faced by medical institutions providing home healthcare. Especially in 2026, which is the year of the “Triple Revision” where medical fees, long-term care fees, and disability welfare service fees are revised simultaneously, the impact on the home healthcare sector, where multi-professional collaboration is essential, is presumed to be significant.

2026 Triple Revision and Home Healthcare Management Strategies

The theme of this seminar, “More Complex Home Healthcare Management,” can be seen as strongly reflecting the changes brought about by the 2026 Triple Revision. In home healthcare, urgent issues include strengthening medical-nursing care collaboration, responding to end-of-life care, promoting medical DX (digital transformation), and maintaining a 24-hour support system. Strengthening these requirements entails a significant burden on maintaining facility standards, staffing, and capital investment, making it increasingly difficult for a single medical institution to fulfill all of them. To cope with this complexity, not only a single-year financial plan but also a medium-to-long-term management strategy spanning multiple years and a business succession strategy to support it are indispensable.

Pursuing Economies of Scale and Group Participation through M&A

The point in the news, “Economies of Scale: Group participation that can disperse the burden of maintaining facility standards and capital investment,” is one of the important motivations for M&A in the home healthcare sector. For example, the costs associated with securing multiple doctors and nurses necessary for maintaining a 24-hour support system, introducing and operating electronic medical record and online consultation systems for promoting medical DX, and formulating and executing a disaster BCP (Business Continuity Plan) can be efficiently dispersed and absorbed as the scale increases. For clinics with no successor or medical corporations feeling the limits of their management resources, joining a medical group with a stronger management foundation can be an effective option to ensure business continuity and maintain contributions to regional healthcare. For the acquiring party, benefits such as expanding home healthcare bases, acquiring multi-professional collaboration know-how, and improving presence within the community-based integrated care system can be expected.

Importance of Medical Corporation Type Changes and Tax Strategies

The point “Tax Schemes: Utilizing tax incentives including transition to specified medical corporations or social medical corporations” is also extremely important in home healthcare M&A and business succession. While transitioning to a specified medical corporation or social medical corporation can provide significant tax benefits such as corporate tax exemption, the requirements (contribution to regional healthcare, thorough non-profit nature, board member composition, etc.) are strict. When considering M&A, the presence or absence of equity interests in the medical corporation being transferred significantly affects capital gains tax. In the case of a medical corporation with equity interests, capital gains tax is incurred on the appraised value of the equity interests, which directly impacts the net proceeds for the selling director. Therefore, considering a comprehensive tax strategy in advance, including transition to a medical corporation without equity interests, conversion to a foundation-contributing medical corporation, or inheritance tax measures, is essential for smooth business succession and M&A.

If you are specifically considering business succession or M&A for a medical corporation or clinic, please use our free quick assessment or individual consultation (strict confidentiality and fully success-based fee system).